Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Celgene Corporation,Australasian Leukaemia and Lymphoma Group (ALLG)
Scientific Title
A multicenter, single arm, study of daratumumab-lenalidomide-dexamethasone (DRd) for newly diagnosed transplant eligible multiple myeloma patients who fail bortezomib-based induction therapy